Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

08.01.2018

2 Am J Surg
5 Ann Oncol
1 Ann Surg
6 BMC Cancer
1 BMJ
2 Breast Cancer
7 Breast Cancer Res
4 Breast Cancer Res Treat
2 Cancer Res
6 Clin Breast Cancer
1 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Cancer
1 Exp Cell Res
1 Int J Radiat Oncol Biol Phys
3 J Clin Oncol
1 Lancet Oncol
1 Oncogene
1 Oncology (Williston Park)
5 PLoS One
5 Radiother Oncol



    Am J Surg

  1. LABGAA I, Slankamenac K, Schadde E, Jibara G, et al
    Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Am J Surg. 2018;215:125-130.
    >> Share

  2. RHEE D, Pockaj B, Wasif N, Stucky CC, et al
    Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies.
    Am J Surg. 2018;215:151-154.
    >> Share


    Ann Oncol

  3. PRUNERI G, Lazzeroni M, Bagnardi V, Tiburzio GB, et al
    The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
    Ann Oncol. 2017;28:321-328.
    >> Share

  4. SWAIN SM, Schneeweiss A, Gianni L, Gao JJ, et al
    Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab.
    Ann Oncol. 2018 Jan 2. pii: 4782676. doi: 10.1093.
    >> Share

  5. KHOSROW-KHAVAR F, Yin H, Barkun A, Bouganim N, et al
    Aromatase Inhibitors and the Risk of Colorectal Cancer in Post-Menopausal Women with Breast Cancer.
    Ann Oncol. 2017 Dec 27. pii: 4779926. doi: 10.1093.
    >> Share

  6. SHARMA P, Barlow WE, Godwin AK, Pathak H, et al
    Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with doxorubicin-based adjuvant chemotherapy (SWOG S9313).
    Ann Oncol. 2017 Dec 23. pii: 4774220. doi: 10.1093.
    >> Share

  7. YANG TO, Cairns BJ, Reeves GK, Green J, et al
    Cancer risk among 21st century blood transfusion recipients.
    Ann Oncol. 2017;28:393-399.
    >> Share


    Ann Surg

  8. TOESCA A, Peradze N, Galimberti V, Manconi A, et al
    Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique.
    Ann Surg. 2017;266:e28-e30.
    >> Share


    BMC Cancer

  9. ZHOU K, He X, Huo L, An J, et al
    Development of the body image self-rating questionnaire for breast cancer (BISQ-BC) for Chinese mainland patients.
    BMC Cancer. 2018;18:19.
    >> Share

  10. NZEANGUNG BA, Biwole ME, Kadia BM, Bechem NN, et al
    Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: a 16-year retrospective review at the Douala general hospital, Cameroon.
    BMC Cancer. 2018;18:32.
    >> Share

  11. LOVITT CJ, Shelper TB, Avery VM
    Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins.
    BMC Cancer. 2018;18:41.
    >> Share

  12. NARRANDES S, Huang S, Murphy L, Xu W, et al
    The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
    BMC Cancer. 2018;18:22.
    >> Share

  13. PATRICIO M, Pereira J, Crisostomo J, Matafome P, et al
    Using Resistin, glucose, age and BMI to predict the presence of breast cancer.
    BMC Cancer. 2018;18:29.
    >> Share

  14. LI M, Li A, Zhou S, Xu Y, et al
    Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
    BMC Cancer. 2018;18:4.
    >> Share


    BMJ

  15. MAYOR S
    Mammography screening reduces breast cancer deaths in Ireland, study finds.
    BMJ. 2017;359:j5932.
    >> Share


    Breast Cancer

  16. PIVOT X, Im SA, Guo M, Marme F, et al
    Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine.
    Breast Cancer. 2018 Jan 4. pii: 10.1007/s12282-017-0826.
    >> Share

  17. PIERRISNARD C, Baciuchka M, Mancini J, Rathelot P, et al
    Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations.
    Breast Cancer. 2017 Dec 29. pii: 10.1007/s12282-017-0828.
    >> Share


    Breast Cancer Res

  18. BARCUS CE, O'Leary KA, Brockman JL, Rugowski DE, et al
    Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
    Breast Cancer Res. 2017;19:9.
    >> Share

  19. TER BRAAK B, Siezen CL, Lee JS, Rao P, et al
    Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
    Breast Cancer Res. 2017;19:14.
    >> Share

  20. SCHOEMAKER MJ, Jones ME, Allen S, Hoare J, et al
    Childhood body size and pubertal timing in relation to adult mammographic density phenotype.
    Breast Cancer Res. 2017;19:13.
    >> Share

  21. ELSHOF LE, Schaapveld M, Rutgers EJ, Schmidt MK, et al
    The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Breast Cancer Res. 2017;19:26.
    >> Share

  22. PILLAI SG, Li S, Siddappa CM, Ellis MJ, et al
    Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
    Breast Cancer Res. 2018;20:2.
    >> Share

  23. HUSS L, Butt ST, Almgren P, Borgquist S, et al
    SNPs related to vitamin D and breast cancer risk: a case-control study.
    Breast Cancer Res. 2018;20:1.
    >> Share

  24. UBELLACKER JM, Haider MT, DeCristo MJ, Allocca G, et al
    Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
    Breast Cancer Res. 2017;19:23.
    >> Share


    Breast Cancer Res Treat

  25. HADDAD TC, D'Assoro A, Suman V, Opyrchal M, et al
    Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Dec 30. pii: 10.1007/s10549-017-4616.
    >> Share

  26. ASADUZZAMAN M, Constantinou S, Min H, Gallon J, et al
    Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
    Breast Cancer Res Treat. 2018 Jan 5. pii: 10.1007/s10549-017-4633.
    >> Share

  27. WANG S, Qian F, Zheng Y, Ogundiran T, et al
    Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.
    Breast Cancer Res Treat. 2018 Jan 4. pii: 10.1007/s10549-017-4638.
    >> Share

  28. KOSTEV K, Kalder M
    20-year risk of breast cancer recurrence.
    Breast Cancer Res Treat. 2018 Jan 3. pii: 10.1007/s10549-017-4636.
    >> Share


    Cancer Res

  29. EMERSON MA, Banegas MP, Chawla N, Achacoso N, et al
    Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0429.
    >> Share

  30. SHARMA C, Wang HX, Li Q, Knoblich K, et al
    Protein Acyltransferase DHHC3 Regulates Breast Tumor Growth, Oxidative Stress, and Senescence.
    Cancer Res. 2017;77:6880-6890.
    >> Share


    Clin Breast Cancer

  31. MEISEL J, Zhang C, Neely C, Mendoza P, et al
    Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
    >> Share

  32. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
    Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
    >> Share

  33. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
    Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
    >> Share

  34. CHANG HT, Pan HJ, Lee CH
    Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
    >> Share

  35. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
    Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
    >> Share

  36. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
    Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
    >> Share


    Clin Cancer Res

  37. DAVILA-GONZALEZ D, Choi DS, Rosato RR, Granados-Principal S, et al
    Pharmacological inhibition of NOS activates ASK1/JNK pathway augmenting docetaxel-mediated apoptosis in triple negative breast cancer.
    Clin Cancer Res. 2018 Jan 4. pii: 1078-0432.CCR-17-1437.
    >> Share


    Clin Exp Metastasis

  38. PRESS DJ, Miller ME, Liederbach E, Yao K, et al
    De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Clin Exp Metastasis. 2017 Dec 29. pii: 10.1007/s10585-017-9871.
    >> Share


    Eur J Cancer

  39. LAVOIE JM, Gelmon KA
    Getting under the skin.
    Eur J Cancer. 2017;82:228-229.
    >> Share


    Exp Cell Res

  40. LUO CW, Wu CC, Chang SJ, Chang TM, et al
    CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
    Exp Cell Res. 2018 Jan 3. pii: S0014-4827(17)30695.
    >> Share


    Int J Radiat Oncol Biol Phys

  41. CHI MS, Yang KL, Chang YC, Ko HL, et al
    Comparing the Effectiveness of Combined External Beam Radiation and Hyperthermia Versus External Beam Radiation Alone in Treating Patients With Painful Bony Metastases: A Phase 3 Prospective, Randomized, Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2018;100:78-87.
    >> Share


    J Clin Oncol

  42. ZIVANOVIC BUJAK A, Dawson SJ
    Circulating Tumor DNA Guides Prognosis in Metastatic Triple-Negative Breast Cancer.
    J Clin Oncol. 2018 Jan 3:JCO2017765461. doi: 10.1200/JCO.2017.76.5461.
    >> Share

  43. BUTOW PN, Turner J, Gilchrist J, Sharpe L, et al
    Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
    J Clin Oncol. 2017;35:4066-4077.
    >> Share

  44. STOVER DG, Parsons HA, Ha G, Freeman SS, et al
    Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.
    J Clin Oncol. 2018 Jan 3:JCO2017760033. doi: 10.1200/JCO.2017.76.0033.
    >> Share


    Lancet Oncol

  45. MALAGA G, Cuba-Fuentes S, Romero-Albino Z
    Implementation of a community-based breast cancer management programme.
    Lancet Oncol. 2018;19:e3.
    >> Share


    Oncogene

  46. LUSTIG LC, Dingar D, Tu WB, Lourenco C, et al
    Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.
    Oncogene. 2017;36:6830-6837.
    >> Share


    Oncology (Williston Park)

  47. KAKLAMANI VG
    Developments in Breast Cancer 2017-2018: New Drugs, New Drug Classes-and the Prospect of More to Come.
    Oncology (Williston Park). 2017;31.
    >> Share


    PLoS One

  48. KROIGARD AB, Larsen MJ, Laenkholm AV, Knoop AS, et al
    Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
    PLoS One. 2018;13:e0189887.
    >> Share

  49. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2018;13:e0190814.
    >> Share

  50. SANNACHI L, Gangeh M, Tadayyon H, Sadeghi-Naini A, et al
    Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    PLoS One. 2018;13:e0189634.
    >> Share

  51. THAKUR SS, Li H, Chan AMY, Tudor R, et al
    The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    PLoS One. 2018;13:e0188983.
    >> Share

  52. OLIVEIRA MMF, Gurgel MSC, Amorim BJ, Ramos CD, et al
    Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.
    PLoS One. 2018;13:e0189176.
    >> Share


    Radiother Oncol

  53. ARISTEI C, Maranzano E, Lancellotta V, Chirico L, et al
    Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study.
    Radiother Oncol. 2017;124:208-213.
    >> Share

  54. MIGNOT F, Ajgal Z, Xu H, Geraud A, et al
    Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review.
    Radiother Oncol. 2017;124:190-199.
    >> Share

  55. BRONSART E, Dureau S, Xu HP, Bazire L, et al
    Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.
    Radiother Oncol. 2017;124:214-219.
    >> Share

  56. BAUMANN BC, Zeng C, Freedman GM, Verginadis II, et al
    Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?
    Radiother Oncol. 2017;124:204-207.
    >> Share

  57. DEMOOR-GOLDSCHMIDT C, Supiot S, Oberlin O, Helfre S, et al
    Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort study.
    Radiother Oncol. 2017;124:200-203.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016